Volume : 11, Issue : 02, February – 2024
Title:
A REVIEW ON RECENT ADVANCES IN OCULAR DRUG DELIVERY SYSTEM
Authors :
Gandrathi Srujana, Dr. Chandrasekhara Rao Baru, Jajala Yeshwanth, Kummari Manikanta, Jadhav Rushikesh
Abstract :
Pharmaceutical researchers find that the ocular drug delivery system (ODDS) is one of the most difficult topics to discuss. The ability to sustain a therapeutic dose of drug at the site of action is the key obstacle to long-term ocular pharmaceutical use. Ailments interfere with the ability to focus for the duration of this eye care. The barriers that shield the eyes make this ocular drug delivery device difficult to use. The main obstacle to be addressed is the active drug substance’s bioavailability. Because topical administration has a faster beginning of effect than systemic use, it is excellent for ocular therapies because a lesser dose is needed. This trans-corneal penetration, which occurs when topical absorption reaches the interior regions of the eye, is thought to be the primary drug application method. The more slower method of removal is called ocular absorption. To treat ocular diseases, this traditional ocular dose form—including eye drops—is no longer enough. Conventional drug therapy is a crucial component of ocular pharmacokinetics and investigates a range of techniques to increase the drug’s ocular bioavailability, including eye ointment, gels, prodrugs, penetration enhancers, liposomes, niosomes, ocular inserts, implants, intravitreal injection, nanoparticles, nanosuspension, microemulsion, iontophoresis, and periocular injection. They supply the medication to the anterior and posterior chambers in a continual and regulated manner.
KEYWORDS: Ocular drug delivery system (ODDS), soluble ophthalmic drug delivery insert (SODI), polyvinyl alcohol (PVA), polyvinyl pyrrolidone (PVP) corneal drug delivery, controlled and sustained drug delivery, anterior and posterior segment delivery challenges.
Cite This Article:
Please cite this article in press Gandrathi Srujana et al., A Review On Recent Advances In Ocular Drug Delivery System, Indo Am. J. P. Sci, 2024; 11 (02).
Number of Downloads : 10
References:
1. Fujiwara T, Margolis R.; Slakter J.S.; Spaide R.F. (References). optical coherence tomography with enhanced depth imaging of the choroid in eyes with high myopia. 2009; Am J Ophthalmol, Vol. 148, pp. 445–450.
2. Spaide R.F. Choroidal atrophy associated with aging. 2009; Vol. 147, No. 1, Am. J. Ophthalmol., 801–810.
3. Jayachandra Reddy P., Chandrasekhar K., and Ramesh Y. The International Journal of Research in Pharmacy and Life Sciences, 2016; 4(1): 65–70, reviewed solid lipid nanoparticles as a means of delivering drugs to the eyes.
4. Fitzgerald P, Hardy JG, Wilson CG, and Zaki I. (1999). Comparing the impact of viscosity on a solution’s precorneal residence in humans and rabbits. 38, 463–466 Journal of Pharmacy and Pharmacology.
5. Agarwal, Sharma, and Jaswal. Current Developments in Ocular Drug Delivery Systems. International J. Pharm. Sci. Rev. May–June 2016, pp. 119–124.
6. Robinson JF and Lee VH (2009). Review: The development of topical ocular drug delivery and its future challenges. Ocular Pharmacology and Therapeutics Journal, 2: 67.
7. Padmapreetha J., Karthika K, and Arul Kumaran KSG (2010). Comparative analysis of advanced and conventional ocular drug delivery formulations, International Journal of Pharmaceutical Sciences and Pharmacy, 2, 1.
8. Malviya R, Sharma PK, and Kumar A (2016). A Brief Overview of Current Developments in Ocular Drug Delivery, European Journal of Applied Sciences, 3, 86–92.
9. Jain Dinesh K., Bavisker Dheeraj T, Kale Sachin S, and Boarse Manoj B. (2013). review of advanced conventional ocular drug delivery systems in comparison. 114–1233, Journal of Drug Delivery and Therapeutics, 3(1).
10. Aceclofenac preparation and assessment by Ravindra Reddy K, Ravi Shankar Yadav M, and Sabitha Reddy P.
11. Needham T, Leverage R, Scar L, Zia H, Sado PA, and Bourlais CL. Recent developments in ophthalmic drug delivery systems. Retinal Prog. Eye Res. 1998;17:33–58.10.1016/S1350- 9462(97)00002-5 is the doi.* PubMed [LinkRef] [Scholastic Google]
12. Chauhan A, Gulsen D. delivery of ophthalmic drugs via contact lenses. Vis Sci Invest Ophthalmol 2004;45:2342–2347. 10.1167/iovs.03-0959 is the doi. * PubMed [Google Scholar] [CrossRef]
13. Volume 2, Issue 1, Ramaiyan Dhanapal, 2012, pages 4–15.
14. Sasaki H, Ichikawa M, Yamamura K, Nishida K, Nakamura J. Drug administration to the eye through application topically. Research on the Retina and Eye, 15 (2), 1996, 553-620.
15. Mitra AK, Macha S. Ophthalmic drug delivery systems: an expanded and revised second edition. Overview of Ocular Drug Delivery, Chapter 1, pages 1-3. 17. Patil AT, Mundada AS, Avari JG, Mehta SP, and Pandit SS. Current developments in drug delivery methods for eyes. 2008; Pharm Rev., 6(1), 481-489